NeurRx Medical offers treatment for ischemic stroke, deep vein thrombosis, and other vascular conditions.
NeuRx Medical has raised $256K in total funding. The most recent round was Grant. The last funding was announced in March 2022.
NeuRx Medical's investors include National Science Foundation.
NeuRx Medical is headquartered in Philadelphia, United States.
NeurRx Medical offers treatment for ischemic stroke, deep vein thrombosis, and other vascular conditions.
NeuRx Medical is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuRx Medical — Funding & Investors." VCBacked, March 6, 2022, https://www.vcbacked.co/company/neurx-medical. Accessed August 13, 2026.
VCBacked. (2022). NeuRx Medical — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/neurx-medical
{{cite web |title=NeuRx Medical — Funding & Investors |url=https://www.vcbacked.co/company/neurx-medical |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated